Boston Angel Investors →
Napa Summit 2013 →
President and CEO, Anadys Pharmaceuticals
Partner, PureTech Ventures
CEO, Cambridge Innovation Center
VP of Venture Capital, Pfizer Inc.
Chairman of the Board, Oncothyreon
Managing Director, Project 11
Chief Scientist, Mimecast
President and CEO, SRI International
(Page 26 of 31)
Luke Timmerman is the National Biotech Editor of Xconomy. E-mail him at firstname.lastname@example.org Follow @ldtimmerman
Pingback: #ApoVaxInSeattle #ImmunexSEA « louisvillelifescience
Pingback: Join Cliff Stocks, Pat Gray, Mike Gallatin & More Nov. 27 for ‘The Icos Impact’ | Xconomy
San Francisco · 6/3/13
Xconomy offers a number of ways to subscribe for free!
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.
© 2007-2013, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.